Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.

Sénat MV, Affres H, Letourneau A, Coustols-Valat M, Cazaubiel M, Legardeur H, Jacquier JF, Bourcigaux N, Simon E, Rod A, Héron I, Castera V, Sentilhes L, Bretelle F, Rolland C, Morin M, Deruelle P, De Carne C, Maillot F, Beucher G, Verspyck E, Desbriere R, Laboureau S, Mitanchez D, Bouyer J; Groupe de Recherche en Obstétrique et Gynécologie (GROG).

JAMA. 2018 May 1;319(17):1773-1780. doi: 10.1001/jama.2018.4072.

2.

Phylogenomic exploration of the relationships between strains of Mycobacterium avium subspecies paratuberculosis.

Bryant JM, Thibault VC, Smith DG, McLuckie J, Heron I, Sevilla IA, Biet F, Harris SR, Maskell DJ, Bentley SD, Parkhill J, Stevenson K.

BMC Genomics. 2016 Jan 26;17:79. doi: 10.1186/s12864-015-2234-5.

3.

Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines.

Kwenda G, Churchyard GJ, Thorrold C, Heron I, Stevenson K, Duse AG, Marais E.

J Water Health. 2015 Mar;13(1):190-202. doi: 10.2166/wh.2014.161.

PMID:
25719478
4.

Culture phenotypes and molecular characterization of Mycobacterium avium subsp. paratuberculosis isolates from small ruminants.

Dimareli-Malli Z, Mazaraki K, Stevenson K, Tsakos P, Zdragas A, Giantzi V, Petridou E, Heron I, Vafeas G.

Res Vet Sci. 2013 Aug;95(1):49-53. doi: 10.1016/j.rvsc.2013.03.010. Epub 2013 Apr 12.

PMID:
23587160
5.

Inter- and intra-subtype genotypic differences that differentiate Mycobacterium avium subspecies paratuberculosis strains.

Biet F, Sevilla IA, Cochard T, Lefrançois LH, Garrido JM, Heron I, Juste RA, McLuckie J, Thibault VC, Supply P, Collins DM, Behr MA, Stevenson K.

BMC Microbiol. 2012 Nov 19;12:264. doi: 10.1186/1471-2180-12-264.

6.

Occurrence of Mycobacterium avium subspecies paratuberculosis across host species and European countries with evidence for transmission between wildlife and domestic ruminants.

Stevenson K, Alvarez J, Bakker D, Biet F, de Juan L, Denham S, Dimareli Z, Dohmann K, Gerlach GF, Heron I, Kopecna M, May L, Pavlik I, Sharp JM, Thibault VC, Willemsen P, Zadoks RN, Greig A.

BMC Microbiol. 2009 Oct 7;9:212. doi: 10.1186/1471-2180-9-212.

7.

Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics.

Short DM, Heron ID, Birse-Archbold JL, Kerr LE, Sharkey J, McCulloch J.

Proteomics. 2007 Sep;7(17):3085-96.

PMID:
17676660
8.

Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death.

Kerr LE, Birse-Archbold JL, Short DM, McGregor AL, Heron I, Macdonald DC, Thompson J, Carlson GJ, Kelly JS, McCulloch J, Sharkey J.

Oncogene. 2007 Apr 19;26(18):2554-62. Epub 2006 Oct 30.

PMID:
17072349
9.

Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus.

Deming MS, Roungou JB, Kristiansen M, Heron I, Yango A, Guenengafo A, Ndamobissi R.

Bull World Health Organ. 2002;80(9):696-703.

10.

[Immunogenicity and safety of Di-Te-Ki-Pol vaccine "SSI" in Danish infants].

Lyngholm E, Gyhrs AF, Bang SM, Heron I.

Ugeskr Laeger. 2000 Aug 21;162(34):4526-30. Danish.

PMID:
10981219
11.

Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine.

Gyhrs A, Lyngholm E, Larsen SO, Aggerbeck H, Heron I.

Scand J Infect Dis. 1999;31(6):579-85.

PMID:
10680989
13.

DTaP vaccines from north american vaccine (NAVA): composition and critical parameters.

Heron I, Chen FM, Fusco J.

Biologicals. 1999 Jun;27(2):91-6. Review.

PMID:
10600191
14.

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

Richmond P, Goldblatt D, Fusco PC, Fusco JD, Heron I, Clark S, Borrow R, Michon F.

Vaccine. 1999 Nov 12;18(7-8):641-6.

PMID:
10547423
15.

Bordetella pertussis and chronic cough in adults.

Birkebaek NH, Kristiansen M, Seefeldt T, Degn J, Moller A, Heron I, Andersen PL, Moller JK, Ostergård L.

Clin Infect Dis. 1999 Nov;29(5):1239-42.

PMID:
10524969
16.

WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines.

Arciniega JL, Corbel M, Dellepiane N, Dobbelaer R, Griffiths E, Heron I, Ivanoff B, Kreeftenberg H, Mastrantonio P, Meade B, Milstein J, Robertson S, Robinson A, Sato H, Sato Y, Schwanig M, Tiru M.

Biologicals. 1998 Sep;26(3):195-204. No abstract available.

PMID:
10208721
17.

Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.

Fusco PC, Michon F, Laude-Sharp M, Minetti CA, Huang CH, Heron I, Blake MS.

Vaccine. 1998 Nov;16(19):1842-9.

PMID:
9795390
18.

Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.

Michon F, Fusco PC, Minetti CA, Laude-Sharp M, Uitz C, Huang CH, D'Ambra AJ, Moore S, Remeta DP, Heron I, Blake MS.

Vaccine. 1998 Nov;16(18):1732-41.

PMID:
9778749
19.

Intranasal vaccination: pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune responses.

Gizurarson S, Aggerbeck H, Gudmundsson M, Heron I.

Pharm Dev Technol. 1998 Aug;3(3):385-94.

PMID:
9742559
21.

Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera.

Kristiansen M, Aggerbeck H, Heron I.

APMIS. 1997 Nov;105(11):843-53.

PMID:
9393555
22.

In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise.

Bruunsgaard H, Hartkopp A, Mohr T, Konradsen H, Heron I, Mordhorst CH, Pedersen BK.

Med Sci Sports Exerc. 1997 Sep;29(9):1176-81.

PMID:
9309628
23.

Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.

Leininger E, Bowen S, Renauld-Mongénie G, Rouse JH, Menozzi FD, Locht C, Heron I, Brennan MJ.

J Infect Dis. 1997 Jun;175(6):1423-31.

PMID:
9180182
24.

Immunity to tetanus and diphtheria in rural Africa.

Kurtzhals JA, Kjeldsen K, Hey AS, Okong'o-Odera EA, Heron I.

Am J Trop Med Hyg. 1997 May;56(5):576-9.

PMID:
9180611
25.

Intranasal booster vaccination against diphtheria and tetanus in man.

Aggerbeck H, Gizurarson S, Wantzin J, Heron I.

Vaccine. 1997 Feb;15(3):307-16.

PMID:
9139491
26.

Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study.

Simonsen O, Kristiansen M, Aggerbeck H, Hau C, Heron I.

APMIS. 1996 Dec;104(12):921-5.

PMID:
9048872
27.
28.

Control of Amblyomma variegatum and dermatophilosis on local and exotic breeds of cattle in Ghana.

Morrow AN, Koney EB, Heron ID.

Trop Anim Health Prod. 1996 May;28(2 Suppl):44S-49S; discussion 74S-86S.

PMID:
8809991
29.

The association between Amblyomma variegatum and dermatophilosis: epidemiology and immunology.

Koney EB, Morrow AN, Heron ID.

Trop Anim Health Prod. 1996 May;28(2 Suppl):18S-25S; discussion 74S-86S.

PMID:
8809987
30.

Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay.

Aggerbeck H, Nørgaard-Pedersen B, Heron I.

J Immunol Methods. 1996 Apr 19;190(2):171-83.

PMID:
8621952
31.

Evaluation of local toxicity after repeated intranasal vaccination of guinea-pigs.

Gizurarson S, Georgsson G, Aggerbeck H, Thorarinsdóttir H, Heron I.

Toxicology. 1996 Jan 22;107(1):61-8.

PMID:
8597032
32.
33.

Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia.

Jurlander J, de Nully Brown P, Skov PS, Henrichsen J, Heron I, Obel N, Mortensen BT, Hansen MM, Geisler CH, Nielsen HJ.

Leukemia. 1995 Nov;9(11):1902-9.

PMID:
7475282
34.

Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivity.

Porter JF, Connor K, van der Zee A, Reubsaet F, Ibsen P, Heron I, Chaby R, Le Blay K, Donachie W.

FEMS Microbiol Lett. 1995 Oct 15;132(3):195-201.

PMID:
7590172
35.
36.
37.
40.

Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum.

Koney EB, Morrow AN, Heron I, Ambrose NC, Scott GR.

Vet Parasitol. 1994 Nov;55(3):245-56.

PMID:
7879382
42.

Bordetella pertussis diagnosed by polymerase chain reaction.

Birkebaek NH, Heron I, Skjødt K.

APMIS. 1994 Apr;102(4):291-4.

PMID:
8011307
43.

Seasonal prevalence of ticks and their association with dermatophilosis in cattle on the Accra plains of Ghana.

Koney EB, Walker AR, Heron ID, Morrow AN, Ambrose NC.

Rev Elev Med Vet Pays Trop. 1994;47(2):163-7.

PMID:
7863064
44.

Reversible opening of the blood-brain barrier by anti-bacterial antibodies.

Tuomanen EI, Prasad SM, George JS, Hoepelman AI, Ibsen P, Heron I, Starzyk RM.

Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7824-8.

45.

Identification of B-cell epitopes on the S4 subunit of pertussis toxin.

Ibsen PH, Holm A, Petersen JW, Olsen CE, Heron I.

Infect Immun. 1993 Jun;61(6):2408-18.

46.
47.

[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog].

Heron I, Thomas F, Dero M, Poutrain JR, Henane S, Catus F, Kuhn JM.

Presse Med. 1993 Mar 27;22(11):526-31. French.

PMID:
8099735
48.
49.

Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly.

Heron I, Thomas F, Dero M, Gancel A, Ruiz JM, Schatz B, Kuhn JM.

J Clin Endocrinol Metab. 1993 Mar;76(3):721-7.

PMID:
8095269
50.

Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.

Petersen JW, Andersen P, Ibsen PH, Capiau C, Wachmann CH, Hasløv K, Heron I.

Vaccine. 1993;11(4):463-72.

PMID:
8470432

Supplemental Content

Support Center